Covovax approval welcome news for Covax distribution scheme as Novavax & Serum Institute of India, which produces Covovax under license, have pledged to provide it with 1.1 billion doses.
Pune-based Serum Institute is manufacturing the vaccine apart from the AstraZeneca vaccine Covishield. Covovax could be available by September this year.
Novavax Monday announced that its vaccine was 90.4 per cent effective in preventing mild and moderate Covid in a large trial in the US and Mexico and prevented all severe disease.
In a tweet, Serum Institute of India CEO Adar Poonawalla said, "Our partnership for a Covid-19 vaccine with Novavax has also published excellent efficacy results.”
In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
COMMENTS